Raf265
| CAS No. | 927880-90-8 |
|---|---|
| MDL No. | MFCD16659061 |
| MF | C24H16F6N6O |
| MW | 518.40 |
| InChI Key | YABJJWZLRMPFSI-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
CHIR-265 is a benzimidazole derivative with substituents at positions 1, 2, and 5: methyl, [4-(trifluoromethyl)phenyl]amino, and {2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl}oxy groups. It inhibits RAF kinases, including the BRAF V600E mutant, and functions as an antineoplastic agent, apoptosis inducer, antiviral agent, EC 2.7.10.1 inhibitor, B-Raf inhibitor, and angiogenesis inhibitor. It is an aromatic ether, imidazole, pyridine, organofluorine compound, benzimidazole, substituted aniline, and (trifluoromethyl)benzene.
| CAS No. | 927880-90-8 |
|---|---|
| Product Name | Raf265 |
Biological Targets
BRAF·KDR
Associated Conditions
metastatic melanoma·neoplasm
* The information provided here is compiled from public sources and is for reference only.